2621 - 2630 of 6255 Results
Title
Year
-
OPENTitle: RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03322-1Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12974-024-03322-1.pdfCitation Count: 0
-
OPENTitle: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in MiceJournal Name: NeurosciencePublisher: Elsevier BVVol: 441Issue #:Start Page: 58End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047Best OA location URL: https://doi.org/10.1016/j.neuroscience.2020.05.047Citation Count: 18
-
OPENTitle: New aspects of USP30 biology in the regulation of pexophagyJournal Name: AutophagyPublisher: Informa UK LimitedVol: 15Issue #: 9Start Page: 1634End Page: 1637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1615304?needAccess=trueCitation Count: 14
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations2016OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 18
- Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease2019OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 16
- Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration2018OPENTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 30
- Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models2023OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 6
- Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)2021OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
- Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading2025OPENTitle: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein SpreadingJournal Name: Advanced SciencePublisher: WileyVol: 12Issue #: 25Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202413052Best OA location URL: https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202413052Citation Count: 1
- Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease2014OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68